Evaluation of cetuximab as a candidate for targeted α-particle radiation therapy of HER1-positive disseminated intraperitoneal disease

類似資料

• Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
  著者:: Milenic, Diane E., 等
  出版事項: (2017)
• Comparative Studies on the Therapeutic Benefit of Targeted α-Particle Radiation Therapy for the Treatment of Disseminated Intraperitoneal Disease
  著者:: Milenic, Diane E., 等
  出版事項: (2017)
• Evaluation of Platinum Chemotherapy in Combination with HER2-Targeted α-Particle Radiation
  著者:: Milenic, Diane E., 等
  出版事項: (2013)
• Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts
  著者:: Yong, Kwon Joong, 等
  出版事項: (2016)
• Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel
  著者:: Yong, Kwon Joong, 等
  出版事項: (2014)